Catalyst Pharmaceuticals, Inc. announced that Philip H. Coelho, an independent member of the Board, did not stand for re-election at the Annual Meeting held on August 22, 2023. Mr. Coelho had been a member of the Board since October 2002. His decision to retire from the Board was not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 USD | -1.76% | -3.34% | -10.18% |
Jun. 05 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.18% | 1.81B | |
+0.85% | 92.4B | |
-3.03% | 38.08B | |
-10.65% | 34.05B | |
+74.71% | 27.77B | |
-13.06% | 16B | |
-1.85% | 14.1B | |
-11.15% | 11.91B | |
+169.04% | 10.37B | |
-50.19% | 10.2B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Catalyst Pharmaceuticals, Inc. Announces the Resignation of Philip H. Coelho as Independent Member of the Board